YKL-40 and Complications in Type 2 Diabetes

NCT01387984 | Completed

• 1 other identifier: 201002053R
• Study Type: observational
• Target: 473
• Locations: 1 country
• Sites: 1

Brief Summary

In this study, the investigators plan to establish the relationship between plasma concentration of YKL-40 with various vascular complications in the patients of type 2 diabetes.

Conditions

Type 2 Diabetes Mellitus

Keywords

Type 2 diabetes mellitus; Diabetic complications; YKL-40

Study Arms (1)

Type 2 diabetes mellitus

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The type 2 diabetic patient who receives follow-up at NTUH diabetics caring network

You may qualify if:

• Clear consciousness
• type 2 diabetic patient

Sponsors & Collaborators

• National Taiwan University Hospital: lead
• National Science and Technology Council, Taiwan: collaborator

Study Sites (1)

National Taiwan University Hospital Yun-Lin Branch

Douliu City, Yunlin County, 640, Taiwan

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2; Diabetes Complications

Condition Hierarchy (Ancestors)

Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• Chih-Hung Lin, M.D.

  National Taiwan University Hospital, Yun-Lin Branch

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: July 1, 2011
• First Posted: July 6, 2011
• Study Start: April 1, 2010
• Primary Completion: April 1, 2010
• Study Completion: April 1, 2010
• Last Updated: July 6, 2011

Record last verified: 2011-06

Locations

TW (1)